tetano
Editor, Senior Moderator
PLoS One. 2018 Aug 23;13(8):e0201429. doi: 10.1371/journal.pone.0201429. eCollection 2018.
[h=1]Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine.[/h] Tsybalova LM[SUP]1[/SUP], Stepanova LA[SUP]1[/SUP], Shuklina MA[SUP]1[/SUP], Mardanova ES[SUP]2[/SUP], Kotlyarov RY[SUP]2[/SUP], Potapchuk MV[SUP]1[/SUP], Petrov SA[SUP]1[/SUP], Blokhina EA[SUP]2[/SUP], Ravin NV[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Influenza infection could be more effectively controlled if a multi-purpose vaccine with the ability to induce responses against most, or all, influenza A subtypes could be generated. Conserved viral proteins are a promising basis for the creation of a broadly protective vaccine. In the present study, the immunogenicity and protective properties of three recombinant proteins (vaccine candidates), comprising conserved viral proteins fused with bacterial flagellin, were compared.
[h=4]METHODS:[/h] Balb/c mice were immunized intranasally with recombinant proteins comprising either one viral protein (the ectodomain of the M2 protein, 'M2e') or two viral proteins (M2e and the hemagglutinin second subunit 'HA2' epitope) genetically fused with flagellin. Further, two different consensus variants of HA2 were used. Therefore, three experimental positives were used in addition to the negative control (Flg-his). The mucosal, humoral, and T-cell immune responses to these constructs were evaluated.
[h=4]RESULT:[/h] We have demonstrated that insertion of the HA2 consensus polypeptide (aa 76-130), derived from either the first (HA2-1) or second (HA2-2) virus phylogenetic group, into the recombinant Flg4M2e protein significantly enhanced its immunogenicity and protective properties. Intranasal administration of the vaccine candidates (Flg-HA2-2-4M2e or Flg-HA2-1-4M2e) induced considerable mucosal and systemic responses directed at both the M2e-protein and, in general, the influenza A virus. However, the immune response elicited by the Flg-HA2-1-4M2e protein was weaker than the one generated by Flg-HA2-2-4M2e. These recombinant proteins containing both viral peptides provide complete protection from lethal challenge with various influenza viruses: A/H3N2; A/H2N2; and A/H5N1.
[h=4]CONCLUSION:[/h] This study demonstrates that the intranasal administration of Flg-HA2-2-4M2e recombinant protein induces a strong immune response which provides broad protection against various influenza viruses. This construct is therefore a strong candidate for development as a universal vaccine.
PMID: 30138320 DOI: 10.1371/journal.pone.0201429
Free full text
[h=1]Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine.[/h] Tsybalova LM[SUP]1[/SUP], Stepanova LA[SUP]1[/SUP], Shuklina MA[SUP]1[/SUP], Mardanova ES[SUP]2[/SUP], Kotlyarov RY[SUP]2[/SUP], Potapchuk MV[SUP]1[/SUP], Petrov SA[SUP]1[/SUP], Blokhina EA[SUP]2[/SUP], Ravin NV[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Influenza infection could be more effectively controlled if a multi-purpose vaccine with the ability to induce responses against most, or all, influenza A subtypes could be generated. Conserved viral proteins are a promising basis for the creation of a broadly protective vaccine. In the present study, the immunogenicity and protective properties of three recombinant proteins (vaccine candidates), comprising conserved viral proteins fused with bacterial flagellin, were compared.
[h=4]METHODS:[/h] Balb/c mice were immunized intranasally with recombinant proteins comprising either one viral protein (the ectodomain of the M2 protein, 'M2e') or two viral proteins (M2e and the hemagglutinin second subunit 'HA2' epitope) genetically fused with flagellin. Further, two different consensus variants of HA2 were used. Therefore, three experimental positives were used in addition to the negative control (Flg-his). The mucosal, humoral, and T-cell immune responses to these constructs were evaluated.
[h=4]RESULT:[/h] We have demonstrated that insertion of the HA2 consensus polypeptide (aa 76-130), derived from either the first (HA2-1) or second (HA2-2) virus phylogenetic group, into the recombinant Flg4M2e protein significantly enhanced its immunogenicity and protective properties. Intranasal administration of the vaccine candidates (Flg-HA2-2-4M2e or Flg-HA2-1-4M2e) induced considerable mucosal and systemic responses directed at both the M2e-protein and, in general, the influenza A virus. However, the immune response elicited by the Flg-HA2-1-4M2e protein was weaker than the one generated by Flg-HA2-2-4M2e. These recombinant proteins containing both viral peptides provide complete protection from lethal challenge with various influenza viruses: A/H3N2; A/H2N2; and A/H5N1.
[h=4]CONCLUSION:[/h] This study demonstrates that the intranasal administration of Flg-HA2-2-4M2e recombinant protein induces a strong immune response which provides broad protection against various influenza viruses. This construct is therefore a strong candidate for development as a universal vaccine.
PMID: 30138320 DOI: 10.1371/journal.pone.0201429
Free full text